These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 27833386
1. Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry. Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Shirabe K, Yoshizumi T, Kotoh K, Furusyo N, Hida T, Oda Y, Fujioka T, Honda H. World J Gastroenterol; 2016 Oct 28; 22(40):8949-8955. PubMed ID: 27833386 [Abstract] [Full Text] [Related]
2. Assessment of Nonalcoholic Fatty Liver Disease in Rats Using Quantitative Dynamic Contrast-Enhanced MRI. Wu Z, Cheng ZL, Yi ZL, Xie MW, Zeng H, Lu LJ, Xu X, Shen J. J Magn Reson Imaging; 2017 May 28; 45(5):1485-1493. PubMed ID: 27606822 [Abstract] [Full Text] [Related]
3. Comparative diagnostic accuracy of red cell distribution width-to-platelet ratio versus noninvasive fibrosis scores for the diagnosis of liver fibrosis in biopsy-proven nonalcoholic fatty liver disease. Cengiz M, Ozenirler S. Eur J Gastroenterol Hepatol; 2015 Nov 28; 27(11):1293-9. PubMed ID: 26302023 [Abstract] [Full Text] [Related]
8. Diagnostic value of MRI-derived liver surface nodularity score for the non-invasive quantification of hepatic fibrosis in non-alcoholic fatty liver disease. Catania R, Furlan A, Smith AD, Behari J, Tublin ME, Borhani AA. Eur Radiol; 2021 Jan 28; 31(1):256-263. PubMed ID: 32757050 [Abstract] [Full Text] [Related]
13. Quantitative imaging: quantification of liver shape on CT using the statistical shape model to evaluate hepatic fibrosis. Hori M, Okada T, Higashiura K, Sato Y, Chen YW, Kim T, Onishi H, Eguchi H, Nagano H, Umeshita K, Wakasa K, Tomiyama N. Acad Radiol; 2015 Mar 28; 22(3):303-9. PubMed ID: 25491738 [Abstract] [Full Text] [Related]
15. Diagnostic value of MR-based texture analysis for the assessment of hepatic fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). Cannella R, Borhani AA, Tublin M, Behari J, Furlan A. Abdom Radiol (NY); 2019 May 28; 44(5):1816-1824. PubMed ID: 30788556 [Abstract] [Full Text] [Related]
19. Measurements of serum procollagen-III peptide and M30 do not improve the diagnostic accuracy of transient elastography for the detection of hepatic fibrosis in patients with nonalcoholic fatty liver disease. Ergelen R, Akyuz U, Aydin Y, Eren F, Yilmaz Y. Eur J Gastroenterol Hepatol; 2015 Jun 28; 27(6):667-71. PubMed ID: 25923941 [Abstract] [Full Text] [Related]